The first twice-daily injectable HIV prevention drug based on lenacapavir has received CHMP recommendation for authorization, promising an effective and affordable solution.
Cristina Petrache
Health
Foto pexels.com
Always see our news on Google
Lenacapavir is the first twice-daily injectable drug for the prevention of HIV infection, with 99.9% efficacy in clinical trials. Recommended by the CHMP, this treatment simplifies prevention by eliminating the need for daily tablets. In Romania, where the cost of HIV treatment is high, the new PrEP could reduce costs and improve access for vulnerable people. Approved at European level, this drug represents a significant opportunity to transform HIV prevention into public health policy.
Sources
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o şansă uriaşă pentru prevenţia HIV în România
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o șansă uriașă pentru prevenția HIV în România
Omenirea, mai aproape ca niciodată de a opri virusul HIV. Europa a autorizat tratamentul revoluționar
E.U. regulator approves injectable HIV drug that experts say could help stop transmission
EU regulator approves injectable HIV drug that experts say could help stop transmission
Latest News
22:54
Iulia Navalnaya urges Russians to vote for Yabloko: the September elections, a legal referendum against the war
22:39
The air forces of Bulgaria, Romania, and Spain have signed a trilateral agreement for air policing operations within NATO.
22:30
The government has approved the 'Diaspora Invests at Home' program, which offers grants of up to 200,000 euros to Romanians from the Diaspora for businesses in Romania.
22:22
The crisis in Ceuta unites the Spanish extremes: Sumar and Vox demand the exclusion of Morocco from the 2030 World Cup.
22:14
At the County Emergency Hospital in Miercurea Ciuc, the first two prostate cancer surgeries were performed with the help of the Da Vinci robotic system.
See more news
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
